RxDoctor Payments Data

Brittany Johnson, PA

Medical · Tempe, AZNPI 1790181543

Payments from drug & device makers

$257in general payments, 2019–2025

Across 14 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biodelivery Sciences International, Inc.$63
  • Boston Scientific$43
  • Nevro Corp.$35
  • Aytu Biopharma, Inc.$28
  • Astellas Pharma US Inc$21
  • Novo Nordisk$19
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$257100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$257 in reported general payments places this provider in the 35th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Medicare billing

Part B allowed, 2024
$107,225
Medicare patients
214
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$27,333
JardianceEmpagliflozin46$26,152
TrulicityDulaglutide21$17,107
OzempicSemaglutide15$15,724
Buprenorphine25$12,150
EntrestoSacubitril/Valsartan12$9,566
JanuviaSitagliptin Phosphate15$7,741
Nucynta ErTapentadol Hcl18$7,337
FarxigaDapagliflozin Propanediol12$7,176
MyrbetriqMirabegron14$6,876
TradjentaLinagliptin11$6,627
Enoxaparin Sodium18$5,766
Quetiapine Fumarate ErQuetiapine Fumarate38$5,108
Tresiba Flextouch U-100Insulin Degludec15$4,715
Ondansetron Hcl30$4,070

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$14$17,10721 claims
Novo NordiskOzempic$19$15,72415 claims
Collegium Pharmaceutical, Inc.Nucynta Er$18$7,33718 claims
Astellas Pharma US IncMyrbetriq$21$6,87614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 748 medical providers in Arizona.

Other medical in Tempe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →